Page 264 - PROGRAMME2018

P-410 BMI adversely affect embryo quality and morphokinetics
G. Shrem1, M. Michaeli2, D. Poltov2, N. Asliha2, N. Rotfarb2, E. Shoshan-Karchovsky2, O. Ruzov2, Y. Atzmon2, E. Shalom-Paz3
1Hillel - Yaffe medical center, IVF unit, Hadera, Israel 2Hillel Yaffe Medical Center, IVF unit, Hadera, Israel 3Hillel Yaffe Medical Center, IVF unit, Hadera, Iceland
P-411 Association of weight change since age 18 years and probability of live birth among women undergoing assisted reproduction
M. Arvizu1, M.C. Afeiche2, R. Hauser3, P. John4, C. Jorge5, G. Audrey6
1Harvard University, Nutrition, Boston, U.S.A.
2Harvard T.H. Chan School of Public Health, Nutrition, Boston, U.S.A.
3Harvard T.H. Chan School of Public Health- Massachusetts General Hospital and Harvard Medical, Nutrition- Environmental Health and 3Vincent Obstetrics and Gynecology, Boston, U.S.A.
4Massachusetts General Hospital and Harvard Medical School, Vincent Obstetrics and Gynecology, Boston, U.S.A.
5Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital and Harvard Medical School, Nutrition- Epidemiology- Channing Laboratory, Boston, U.S.A.
6Brigham and Women's Hospital and Harvard Medical School- Harvard T.H. Chan School of Public Health, Nutrition and Channing Laboratory, Boston, U.S.A.
P-412 Predictive models for pregnancy outcomes with non-IVF treatments reveal that protocol choice, not patient-specific factors, are the primary risk for multiple gestations
K. Hunter Cohn1, C. Wellock1, B.T. Miller2, M. Hinckley3, J.N. Gutmann4, C. Benadiva5, J.C. Nulsen5, G. Letterie6, J. Hirshfeld-Cytron7, A.B. Copperman8, P. Yurttas Beim1
1Celmatix Inc., Celmatix, New York, U.S.A.
2Reproductive Medicine Associates of Michigan, Reproductive Endocrinology, Troy, U.S.A.
3Reproductive Science Center of the San Francisco Bay Area, Reproductive Endocrinology, San Ramon, U.S.A.
4Reproductive Medicine Associates of Philadelphia, Reproductive Endocrinology, Philadelphia, U.S.A.
5University of Connecticut School of Medicine, The Center for Advanced Reproductive Services, Farmington, U.S.A.
6Seattle Reproductive Medicine, Reproductive Endocrinology, Seattle, U.S.A. 7Fertility Centers of Illinois, Reproductive Endocrinology, Highland Park, U.S.A.
8Reproductive Medicine Associates of New York, Icahn School of Medicine at Mount Sinai, New York, U.S.A.
P-413 Comparative study of the Poseidon subgroups 1a and 1b low responder IVF cycles
N. Massiah1, P. Fedorcsak1
1Oslo University Hospital, Reproduction Medicine, Oslo, Norway
264